Nosocomial Pneumonia: A Cost-of-Illness Analysis

Abstract

The study gives insight into the structure of incremental cost caused by NP and shows that based on a conservative cost calculation the incremental cost per NP patient is higher for the hospital than for health insurance funds which indicates a significant financial deficit for the hospital. Antibiotics and microbiology together only contribute 6.8% to incremental cost. Therefore in a cost saving initiative their close relationship to length of hospitalization must be considered.

Examination with Next-Generation Sequencing Technology of the Bacterial Microbiota in Bronchoalveolar Lavage Samples after Traumatic Injury

“…Trauma patients who develop ventilator-associated or community-acquired pneumonia have an increased hospital length of stay and more days of mechanical ventilation than do similarly injured patients who do not develop pneumonia [1][2][3]. A crucial aspect of the proper management of pneumonia is early detection and proper identification of the causative pathogen, which allows aggressive, targeted antibiotic therapy.…”

Preventing healthcare-associated infection through education: Have surgeons been overlooked?

“…Given the cost of VAP [24,25], these programmes have shown themselves to be remarkably cost effective.…”

Epidemiology and Clinical Impact of Glycopeptide Resistance in Staphylococcus aureus

“…A systematic audit of studies describing economic aspects of nosocomial infections revealed that costs for MRSA infections were highest with a mean of $35,367 [111]. A large fraction of additional costs that are attributed to the development of a nosocomial infection results from the prolonged hospital stay, rather than from the use of antibiotics to treat these infections [112]. The distribution of cost between hospital stay and costs of antibiotics might be different for infections caused by hVISA or VISA, especially if these infections are treated with relatively expensive antibiotics such as linezolid.…”